Fig. 6From: A multi-parametric prognostic model based on clinical features and serological markers predicts overall survival in non-small cell lung cancer patients with chronic hepatitis B viral infectionKaplan–Meier analyses of OS according to the prognostic model risk score classifier in subgroups of NSCLC (HBV+) patients in the training cohort (left) and the validation cohort (right): (a) total patients; (b) stage I/II; (c) stage III/IVBack to article page